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 The STABLE™ trial is 
an important milestone 
in the development of 
novel, minimally invasive 
treatments for thoracic  
aortic dissections
THOMAS JEFFERSON UNIVERSITY AND HOSPITALS
When James Blassingame, 79, and his 
wife returned home from church one 
Sunday, he bent down and could not 
stand back up, doubled over in pain. 
He was rushed to a local hospital, 
where Joseph Lombardi, MD, director 
of the new Jefferson Aortic Center and 
Associate Professor of Surgery was 
called for consultation. Dr. Lombardi 
diagnosed Mr. Blassingame with a  
Type B dissection of his thoracic aorta. 
Mr. Blassingame was transferred to the 
Thomas Jefferson University Hospital for 
surgery where he became the first patient 
in the U.S. to enroll in the STABLE™ 
Aortic Dissection clinical trial. “The 
STABLE trial is an important milestone 
in the development of novel, minimally 
invasive treatments for thoracic aortic 
dissections,” explains Dr. Lombardi,  
who is global Principal Investigator (PI) 
of the study. 
Mr. Blassingame, a retired staffing 
specialist for the federal government, 
is grandfather to 18 grandchildren and 
seven great grandchildren. “At my age, 
I was concerned about having any kind 
of surgery,” he recalls. “I thought I could 
just do without it, especially knowing 
that open surgery could be fatal. But 
my daughter, who is a licensed nurse 
practitioner, explained how important 
and non-invasive this surgery was, 
and how it would really help to reduce 
the risks of complications or worse.” 
Performing Mr. Blassingame’s surgery 
with Dr. Lombardi was Robert A. 
Larson, MD, Assistant Professor of 
Surgery, who serves as the site PI for 
the STABLE™ trial. This trial and other 
new programs at Jefferson led to the 
expansion and renaming of the Division 
of Vascular and Endovascular Surgery.
Endovascular surgery directs therapy 
through catheters and wires placed 
within the blood vessels. The stents hold 
open the wall of the weakened vessel, 
First U.S. Patient Enrolls in  
Groundbreaking Clinical Trial at Jefferson
Mr. James Blassingame, the first patient in the U.S. to enroll in the STABLE™ Aortic Dissection  
clinical trial, contemplates the morning from his front porch several months after his operation.
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James Blassingame was a perfect 
candidate for participation in the 
STABLE™ Aortic Dissection clinical 
trial. Given the combination of his  
age, medical history, and what we  
were able to learn from our pre-surgical 
vascular mapping, we knew that we 
could successfully treat him with the 
Cook Zenith™ Dissection Endovascular 
System. The technology we now have 
enables us to treat patients like James 
in a way that radically reduces risks and 
decreases the recovery period. 
In Mr. Blassingame’s case, our three-
dimensional TeraRecon workstation 
was critical in determining if he was 
anatomically suitable for endovascular 
surgery. We used the 3D imaging to 
measure the size of the vessel and to 
determine how much to treat. It is the 
ultimate planning tool—enabling you 
to visualize the procedure, select the 
right devices, and see in advance exactly 
where the weakened vessel begins and 
ends. Once planned, the operation 
was performed with state of the art 
equipment in our new endovascular 
operating suite.
Joseph V. Lombardi, MD, (shown left) 
and Robert A. Larson, MD
 
The Surgeons Speak
and the endovascular grafts – fabric 
tubes used to make a new path for the 
blood to flow – are placed inside the 
vessel. This minimally invasive method 
spares patients the trauma and risk of 
open surgery, decreases recovery time, 
and improves quality of life following  
the procedure.
“The STABLE™ trial will significantly 
help treat a condition that affects tens of 
thousands of people just like James every 
year,” says Dr. Lombardi. “This truly is a 
remarkable, lifesaving advancement.”  
 
For more information about 
endovascular surgery visit:  
www.jeffersonhospital.org/aortic 
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 Charles J. Yeo, MD
Samuel D. Gross Professor and  
Chair, Department of Surgery
This fall, as we welcome new PGY1 
residents and a host of new faculty 
members, there is great excitement here  
in the Department of Surgery.
On the clinical front, we have gained 
additional work at the Methodist Hospital, 
have grown the Heart Transplant and 
Advanced Heart Failure Program, have seen 
an upswing in liver transplants, and are now 
the busiest hospital by surgical volume for 
pancreas resections in the tri-state area!  
On the quality front, Dr. Herbert Cohn and 
Randi Altmark, RN, BSN, CNOR have done 
a tremendous job with the National Surgical 
Quality Improvement Program. Using those 
data we have organized the Surgical Care 
Committee and new Surgical Care Bundle 
and are driving changes in practice, and 
hopefully, better outcomes.
On the research front, our grant submissions 
have doubled in the last three years. 
Total grant awards for the last fiscal year 
approached $2 million. We have completed 
a large prospective randomized trial looking 
at pancreaticojejunostomy following the 
Whipple procedure, and have clinical trials 
open in the Divisions of Vascular, Cardiac, 
Transplant and General Surgery. 
On the education front, Dr. Karen Chojnacki 
has done a great job retooling our surgical 
curriculum with the help of Drs. Niels 
Martin and Vincent Armenti, and the  
Chief Residents.
Finally, we thank Lara Allan Goldstein for her 
work in greatly increasing the department’s 
development dollars – most recently 
accepting a generous gift from the Nicoletti 
family to support an endowed professorship 
in transplant surgery.
The Jefferson Pancreas Tumor Registry 
(Jeff PTR) has been approved by the 
Institutional Review Board of Thomas 
Jefferson University Hospital and is 
designed to help determine the links 
between familial genetic variations, 
environmental and occupational 
influences, and the development of 
pancreatic cancer
According to Principal Investigator, 
Dr. Charles J. Yeo, “The purpose of the 
Jeff PTR is to determine whether 
pancreas cancer occurs more frequently 
in families with a history of the disease, 
and to determine the environmental and 
occupational risk factors to which 
pancreas cancer patients have been 
exposed.” Participants will complete a 
detailed questionnaire and may be asked 
to submit a blood sample and/or cheek 
swab. The questionnaire is designed to 
elicit the family health history of a 
patient with pancreas cancer or a non-
affected family member, and to 
document exposure to occupational and 
environmental factors, such as residential 
radon, asbestos, and second-hand 
tobacco smoke. The Jeff PTR is a 
longitudinal study in which participants 
may engage in long-term follow-up and 
receive information regarding scientific 
and epidemiological breakthroughs in 
pancreas cancer. 
Research has shown that certain rare 
genetic conditions are associated with an 
increased risk of pancreatic cancer, 
including familial breast-ovarian cancer, 
familial melanoma, familial colon cancer, 
hereditary pancreatitis, and Peutz-Jegher’s 
Jefferson Pancreas Tumor 
Registry Opens for Enrollment
Meet Our  
Surgical Interns
Jefferson surgeons are 
currently assisted by 
an exceptional group of 
categorical interns, half of 
them Jefferson Medical 
College graduates. These 
doctors, who recently 
matched with Jefferson, 
started on June 20, 2008 (l to r):
Danielle Pineda, MD, Jefferson Medical 
College; Richard Burkhart, MD, Boston 
University School of Medicine;  
Aleksandra Policha, MD, SUNY/Syracuse; 
Daniel Relles, MD, Jefferson Medical College; 
Christina Khan, MD, PhD, University of Illinois; 
Genetic Counselor Sarah Charles, MS, CGC of the Jefferson Kimmel Cancer Center Network 
(JKCCN) educates families about their risk of developing an inherited disorder.
Overview Clinical Integration
Please Welcome
The goal is to diagnose 
pancreatic cancer early when 
it is easier to treat.
and Jason Walls, MD, Jefferson  
Medical College
We are also pleased to welcome back 
two additional Jefferson Medical College 
graduates, Carrie Houssock, MD, and Jordan 
Goldhammer, MD, as preliminary interns in 
General Surgery. 
syndrome. Genetic Counselor Sarah 
Charles, MS, CGC of the Jefferson 
Kimmel Cancer Center Network 
(JKCCN) educates families about their 
risk of developing an inherited disorder. 
Ms. Charles explains, “We haven’t yet 
identified a causative gene to allow 
predictive testing for pancreatic cancer. 
But, for patients with a strong family 
history of pancreatic cancer, we can offer 
risk assessments and possibly surveillance 
with endoscopic ultrasound.”
Such high risk patients may be 
referred to Jefferson gastroenterologists 
such as Thomas Kowalski, MD and 
David Loren, MD to discuss the pros and 
cons of invasive surveillence. The goal is 
to diagnose pancreatic cancer early when 
it is easier to treat. For persons who do 
develop pancreatic cancer, Jefferson 
physicians may use the results of genetic 
testing to select the most effective 
therapy. Targeted therapy for pancreas 
cancer is becoming a reality in part due 
to recent discoveries made in the 
laboratory of Jonathan Brody, PhD, 
Assistant Professor of Surgery, where 
molecular studies have clearly indicated 
survival advantages with the use of 
targeted chemotherapy treatment. 
For more information about the Jefferson  
Pancreas Tumor Registry please visit  
www.jeffersonhospital.org/pancreasregistry
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Surgical Residents and PhD 
Candidate Make Significant 
Contributions to Ongoing Adult 
Stem Cell Research
Paul DiMuzio, MD, directs the Vascular 
Tissue Engineering Laboratory within 
the Department of Surgery at Thomas 
Jefferson University. “The overall goal  
of our research is to develop a durable 
blood vessel replacement for those 
patients who do not have enough of their 
own tissues for heart or leg bypass surgery 
or hemodialysis access. We combine 
tissue engineering techniques with adult 
stem cell technology to make such a 
graft,” explains Dr. DiMuzio. Specifically, 
the researchers repopulate a cadaver 
blood vessel with the patient’s own stem 
cells (isolated from their fat) that have 
been changed into endothelial cells.
Recent work has focused on the effects 
of fluid-induced shear stress and genetic 
manipulation on the differentiation 
of the stem cells. The investigators are 
developing methods to more effectively 
change the stem cells into endothelial 
cells by altering their environment 
as well as their genetic composition. 
The following research trainees have 
investigated these issues under the 
mentorship of Dr. DiMuzio:
During his research year, Eric Hager, 
MD, a 4th year resident, studied 
how fluid flow influences stem cell 
adhesion to the vascular graft. Dr. 
Hager successfully demonstrated that 
shear stress improves the ability of stem 
cells to adhere to grafts secondary to 
up-regulation of integrin expression 
(proteins on the cell surface necessary for 
cell adhesion). Dr. Hager presented this 
work at the Society of Vascular Surgery’s 
National Annual meeting in June, 2008 
in San Diego—a presentation highlighted 
in a press release at the meeting.
Neil Moudgill, MD, another 4th year 
resident, evaluated the role of shear 
stress on stem cell differentiation. He 
found that shear stress significantly 
up-regulated certain endothelial cell-
specific proteins due to stimulation of a 
specific differentiating pathway. His work 
was presented at the Annual Resident 
Research Competition at the University 
of Rochester in April, 2008. Neil’s 
presentation was picked as one of three 
winners in this national competition.
While surgical residents spend one year 
in the research laboratory, Stephen 
McIlhenny, BS, is currently in his fourth 
year as a PhD candidate in Jefferson’s 
Tissue Engineering and Regenerative 
Medicine (T.E.R.M.) program. Stephen 
designed a novel vascular bioreactor 
in which the stem cell vascular graft is 
created and cultured. He successfully 
demonstrated that a gradual increase in 
shear stress was critical to the retention 
of stem cells on the graft, work that 
he presented at the 2007 Biomedical 
Engineering Society (BMES) Annual 
Meeting in Los Angeles.
Additionally, Stephen recently genetically 
manipulated the stem cells to express 
endothelial nitric oxide synthase (eNOS), 
a gene critical for function of endothelial 
cells. Most importantly, Steven 
demonstrated that this manipulation has 
led to the release nitric oxide (NO), a 
molecule critical to blood vessel function 
and health. Steven’s research on stem cell 
eNOS transfection will be presented at 
the Tissue Engineering and Regenerative 
Medicine International Society 
(TERMIS) meeting in December 2008.
Under the sponsorship of Thomas 
Tulenko, PhD, Director of the Division 
of Research, and Dr. DiMuzio, Stephen 
has been granted an American Heart 
Association Pre-doctoral Fellowship.
Tanya Wynder,
MSN, CRNP, NP-C 
Tanya Wynder is one of two  
Transplant Surgery Nurse Practitio-
ners in the Department of Surgery. 
She came to Jefferson in April 2006 
from Temple University Hospital. 
Can you describe your role as a 
Transplant Nurse Practitioner?
I am deeply involved in patients’ 
pre- and post-operative care, 
including patient assessment, history, 
and physicals. I provide direct care 
immediately after surgery for patients 
at the hospital as well as outpatients  
at the clinic. In 2007, we transplanted 
63 livers, 47 kidneys, and 3  
pancreases at Jefferson.
What’s the best part of your job?
Well, there are really two things.  
First are the people I work with.  
Here, nurse practitioners are truly 
valued and have an important role. 
That goes a long way in my job 
satisfaction. Second is getting to 
know pre-transplant patients and 
then to see the real transformation 
the surgery brings to their lives. For 
example, kidney recipients no longer 
need dialysis 4 hours a day for 3 days 
a week—that’s more than 600 hours a 
year that they get back. Imagine what 
you would do with an extra 600 hours 
a year!
How did you become interested in 
transplant surgery?
When I was younger, my father 
needed a heart transplant. He wasn’t 
patient. One day he said “enough”—
he left the hospital and died the next 
day at home. While I am first and 
foremost a professional, I think with 
that experience I bring another layer 
of compassion and understanding to 
my patients and their families.
Stephen McIlhenny, PhD candidate with Drs. Eric Hager and Neil Moudgill.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
The overall goal of our 
research is to develop 
a durable blood vessel 
replacement for those 
patients who do not have 
enough of their  
own tissues.
Changing Lives Through Research On the Job
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Robert and Beatrice Nicoletti 
and their family have generously 
established an endowed 
professorship in honor of Cataldo 
Doria, MD, PhD, FACS, Associate 
Professor of Surgery and Director 
of the Division of Transplantation 
Surgery.
“Dr. Doria literally saved my 
life,” says Robert Nicoletti. “And 
everyone at Jefferson was so 
caring, thoughtful and 
encouraging. I now have a new 
lease on life.”
For four years, Robert’s kidneys 
were progressively failing him –
the result of hypertension, or high 
blood pressure. Robert initially 
concealed his worsening 
condition from his close knit 
family. In early 2006, however, 
the team at Jefferson determined 
that he needed a transplant and 
Robert told his family. 
Seven members of the Nicoletti 
family immediately volunteered 
to donate a kidney. Ultimately, 
only one family member was 
deemed compatible: Robert’s 
daughter, Lori Peruto. She recalls, 
“When we learned of Dad’s 
condition, we knew what we had 
to do. There was no question, no 
hesitation.” 
On June 6, 2006, Robert and 
Lori arrived at Jefferson for the 
life-changing procedure. Beatrice 
Nicoletti was truly impressed  
with her family’s experience at 
Jefferson. “When something like 
this happens, you’re scared,” she 
says, “but the staff at Jefferson kept 
us informed every step of the way. 
That helped ease our fears.”  
Robert and Lori quickly regained 
their strength and returned to their 
normal lifestyle in a few weeks. 
Both remain in good health, which 
they attribute to Dr. Doria and the 
multidisciplinary team at Jefferson. 
“We knew we were in good 
hands,” Beatrice says. 
Endowed professorships such 
as this are a critical resource to 
recruit and retain a distinguished 
faculty, and they provide distinct 
honor and recognition for the 
faculty members who hold them. 
“This provides a reliable source 
of funding as we seek to expand 
our growing transplant program 
here at Jefferson,” says Dr. Doria. 
“We are all extremely grateful to 
the Nicoletti family for their 
generous gift.”
Jefferson’s Eakins Legacy Fund 
will match this gift dollar-for-
dollar. The Fund was created from 
the proceeds of the sale of Thomas 
Eakins’s The Gross Clinic to 
support the institution’s key 
initiatives.  
 
For additional information on the  
Eakins Legacy Fund and ways to support 
the Department of Surgery, please 
contact Lara Allan Goldstein, Director  
of Development, at 215-955-8797.
The Nicoletti Family 
Professorship in 
Transplantation 
Surgery
Kristin Brill, MD
Those Who Give News in Brief 
SurgicalSolutions
Cataldo Doria, MD, PhD, FACS with Robert and Beatrice Nicoletti, and  
their daughter Lori Peruto
Kristin Brill, MD has joined the 
Department of Surgery’s Division of 
General Surgery after seven years as a 
volunteer faculty member in private 
practice. She specializes in breast surgery.
Michel Haddad, MD has joined the 
Department of Surgery’s Division of 
Cardiothoracic Surgery. He specializes in 
ventricular assist devices, minimally invasive and minimal access 
cardiac surgery, and cardiac ICU care.
Jay Jenoff, MD and Niels Martin, MD have joined the Department 
of Surgery’s Division of Acute Care Surgery. Both surgeons recently 
completed a Fellowship in Traumatology & Surgical Critical Care 
at the Hospital of the University of Pennsylvania. Dr. Jenoff is a 
2005 graduate of the Deparment’s residency program. Dr. Martin, 
a 2006 graduate of the residency program, has also been named the 
Associate Program Director.
Harish Lavu, MD has joined the Department of Surgery’s  
Division of General Surgery. He recently completed a Fellowship 
in Hepatobiliary and Pancreatic Surgery at the Indiana School of 
Medicine in Indianapolis.
John Pinckney Maxwell IV, MD recenty completed his Fellowship  
in Colon and Rectal Surgery at Thomas Jefferson University Hospital 
and has joined the Department of Surgery’s Division of Colon and 
Rectal Surgery. 
Benny Weksler, MD, MBA, has joined the Department of Surgery’s 
Division of Cardiothoracic Surgery. He recently completed a 
fellowship in minimally invasive surgery at the University of 
Pittsburgh Medical Center after several years in private practice in 
Brazil. He specializes in thoracic surgical oncology. 
Gerald Isenberg, MD was named the President of the Association of 
Program Directors for Colorectal Surgery.
Save the Date: November 1, 2008 
Third Annual Pancreatic Cancer Patient Symposium  
Registration required. For more information, go to 
www.jeffersonhospital.org/pancreas
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